e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunogen Inc
(NQ:
IMGN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunogen Inc
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Minim (MINM) Stock Soars 77% After Receiving Nasdaq Deficiency Notice
November 30, 2023
Minim stock is taking off with heavy trading of MINM shares on Thursday despite the company getting a delisting warning.
Via
InvestorPlace
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
November 30, 2023
ImmunoGen stock is taking off on news that AbbVie is acquiring all outstanding shares of IMGN in a $10.1 billion acquisition deal.
Via
InvestorPlace
AbbVie To Buy ImmunoGen, Cancer Drug Maker, In $10.1 Billion Cash Deal
November 30, 2023
IMGN stock soared after AbbVie agreed to buy ImmunoGen for $10.1 billion, offering a rich premium for the maker of cancer drug Elahere.
Via
Investor's Business Daily
ImmunoGen Inc. (NASDAQ: IMGN) Near Top of Volume Charts in Thursday Trading
November 30, 2023
Via
Investor Brand Network
La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday
November 30, 2023
U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Health Care Company AbbVie Announces Acquisition of Immunogen
November 30, 2023
Via
Benzinga
Where Immunogen Stands With Analysts
November 20, 2023
Via
Benzinga
What 4 Analyst Ratings Have To Say About Immunogen
November 03, 2023
Via
Benzinga
Dow Jumps Around 200 Points; US Core PCE Inflation Slows In October
November 30, 2023
U.S. stocks traded mostly higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market opening Thursday, the Dow traded up 0.56% to 35,630.09 while the...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
IMGN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of ImmunoGen, Inc. Is Fair to Shareholders
November 30, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 30, 2023
Via
Benzinga
These Three Biotech Stocks Are Trading At A Discount
November 23, 2023
Investors exposed to the biotech sector have seen mixed results this year.
Via
Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
November 17, 2023
Via
Benzinga
CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News
November 17, 2023
CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Clears Benchmark, Hits 80+ RS Rating
November 17, 2023
Madrigal Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.
Via
Investor's Business Daily
9 Health Care Stocks With Whale Alerts In Today's Session
November 16, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 15, 2023
Via
Benzinga
ImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies London Healthcare Conference
November 02, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Reports Recent Progress and Third Quarter 2023 Financial Results
November 02, 2023
From
ImmunoGen Inc.
Via
Business Wire
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 01, 2023
From
ImmunoGen, Inc.,
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
October 27, 2023
Via
Benzinga
ImmunoGen Announces European Medicines Agency Acceptance of Marketing Authorization Application for Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
October 27, 2023
From
ImmunoGen, Inc.
Via
Business Wire
ImmunoGen Announces Conference Call to Discuss Its Third Quarter 2023 Operating Results
October 19, 2023
From
ImmunoGen Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
October 11, 2023
Via
Benzinga
Sutro Biopharma's Lead Ovarian Cancer Candidate Is A Game Changer, Analyst Sees Huge Upside
October 06, 2023
Oppenheimer initiated coverage on Sutro Biopharma Inc (NASDAQ: STRO), representing around 200% potential upside.
Via
Benzinga
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 29, 2023
From
ImmunoGen, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
ELAHERE® Shows Overall and Progression-Free Survival Benefit Regardless of Prior PARPi Exposure or Prior Lines of Therapy in FRα-Positive Platinum-Resistant Ovarian Cancer
September 28, 2023
From
ImmunoGen Inc.
Via
Business Wire
On the Road to Halving Cancer: The 2023 Biotech Advancements Igniting Hope
September 20, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 20, 2023 – USA News Group – Earlier this year, the US White House requested over $2.8 billion in funding from Congress...
Via
FinancialNewsMedia
ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 18, 2023
From
ImmunoGen, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
